Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Liabilities from Discontinued Operations: 2016

Historic Liabilities from Discontinued Operations for Niagen Bioscience (NAGE) over the last 1 years, with Dec 2016 value amounting to $184,766.

  • Niagen Bioscience's Liabilities from Discontinued Operations was N/A to $184,766 in Q4 2016 from the same period last year, while for Dec 2016 it was $184,766, marking a year-over-year change of. This contributed to the annual value of $184,766 for FY2016, which is N/A change from last year.
  • As of FY2016, Niagen Bioscience's Liabilities from Discontinued Operations stood at $184,766.
  • In the past 5 years, Niagen Bioscience's Liabilities from Discontinued Operations registered a high of $184,766 during FY2016, and its lowest value of $184,766 during FY2016.
  • In the last 1 years, Niagen Bioscience's Liabilities from Discontinued Operations had a median value of $184,766 in 2016 and averaged $184,766.